NARA Discovery
Article Details
← Back to Search Results
Journal Article

The catalytic and structural basis of archaeal glycerophospholipid biosynthesis

Niels A. W. de Kok; Arnold J. M. Driessen
Extremophiles · Vol. 26, Issue 3 · 2022

Abstract

Archaeal glycerophospholipids are the main constituents of the cytoplasmic membrane in the archaeal domain of life and fundamentally differ in chemical composition compared to bacterial phospholipids. They consist of isoprenyl chains ether-bonded to glycerol-1-phosphate. In contrast, bacterial glycerophospholipids are composed of fatty acyl chains ester-bonded to glycerol-3-phosphate. This largely domain-distinguishing feature has been termed the “lipid-divide”. The chemical composition of archaeal membranes contributes to the ability of archaea to survive and thrive in extreme environments. However, ether-bonded glycerophospholipids are not only limited to extremophiles and found also in mesophilic archaea. Resolving the structural basis of glycerophospholipid biosynthesis is a key objective to provide insights in the early evolution of membrane formation and to deepen our understanding of the molecular basis of extremophilicity. Many of the glycerophospholipid enzymes are either integral membrane proteins or membrane-associated, and hence are intrinsically difficult to study structurally. However, in recent years, the crystal structures of several key enzymes have been solved, while unresolved enzymatic steps in the archaeal glycerophospholipid biosynthetic pathway have been clarified providing further insights in the lipid-divide and the evolution of early life.

Bibliographic Information

JournalExtremophiles
PublisherSpringer
Publication Date2022-12-01
Publication Year2022
Volume26
Issue3
Document TypeJournal Article
Print ISSN1431-0651
eISSN1433-4909
DOI10.1007/s00792-022-01277-w

Access Information

NARA Access Coverage1997-01-01~Current
Journal Homepagehttps://www.springer.com/journal/792
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.